Literature DB >> 12514574

The prevalence and natural history of aortic aneurysms in heart and abdominal organ transplant patients.

Michael J Englesbe1, Audrey H Wu, Alexander W Clowes, R Eugene Zierler.   

Abstract

OBJECTIVE: The purpose of this study was to document the prevalence and clinical features of aortic aneurysms in heart and abdominal transplant patients.
METHODS: We undertook a retrospective review of 1557 patients who had heart, liver, or kidney transplantation between January 1, 1987, and December 31, 2000. Aortic aneurysms were identified by computed tomographic scan, ultrasound scan, or at the time of surgery for rupture. An aortic diameter of 3.5 cm was used as the threshold for the definition of aneurysmal disease. We compared dichotomous variables with Fisher's exact test and continuous variables with the Wilcoxon rank-sum test.
RESULTS: There were 296 heart, 450 liver, and 811 kidney transplants performed on adult patients during the study period. We identified 18 transplant patients who had an aortic aneurysm (13 heart, three liver, two kidney). Seven patients (41%) had rupture of the aortic aneurysm, and five of these patients died. There were no deaths from causes other than aortic aneurysm rupture. The rate of aneurysm rupture was 22.5% per year. Eight patients had the aortic aneurysm repaired electively with no deaths and no hospital stay greater than 15 days. The mean aortic aneurysm size at rupture was 6.02 +/- 0.86 cm, and the smallest aneurysm that ruptured was 5.1 cm. The pretransplant rate of aortic aneurysm expansion was 0.46 cm/y, but this increased to 1.00 cm/y after transplantation (P =.08). The rate of aortic aneurysm expansion among heart transplant patients and abdominal transplant patients was the same (P =.51). The prevalence of aortic aneurysm was 4.1% in cardiac transplant patients and 0.4% in abdominal transplant patients. Earlier in our series (1987 to 1996), 11% of the cardiac transplant patients were screened for aortic aneurysms, and the prevalence rate of diagnosis was 3.0%. Screening of cardiac transplant candidates became more frequent in 1997 (87% screened), with an associated increase in the aortic aneurysm prevalence rate to 5.8% in the patients who were screened.
CONCLUSION: Aortic aneurysms in cardiac and abdominal transplant patients have an aggressive natural history with high expansion and rupture rates. Screening transplant patients for aortic aneurysms will increase detection and facilitate elective repair, which is generally well tolerated. These findings support programs for early detection and elective treatment of aortic aneurysms in organ transplant patients, particularly those having heart transplants.

Entities:  

Mesh:

Year:  2003        PMID: 12514574     DOI: 10.1067/mva.2003.57

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  9 in total

1.  Type B aortic dissection triggered by heart transplantation in a patient with Marfan syndrome.

Authors:  Tjorven Audenaert; Michel De Pauw; Katrien François; Julie De Backer
Journal:  BMJ Case Rep       Date:  2015-10-16

2.  Repair of abdominal aortic aneurysm in heart transplant patients: before or after left ventricular assist device implantation?

Authors:  G S Mehta; C M Bhamidipati; D J LaPar; G Ailawadi; J A Kern
Journal:  Thorac Cardiovasc Surg       Date:  2011-03-07       Impact factor: 1.827

3.  Smooth muscle cells from abdominal aortic aneurysms are unique and can independently and synergistically degrade insoluble elastin.

Authors:  Nathan Airhart; Bernard H Brownstein; J Perren Cobb; William Schierding; Batool Arif; Terri L Ennis; Robert W Thompson; John A Curci
Journal:  J Vasc Surg       Date:  2013-09-27       Impact factor: 4.268

Review 4.  Abdominal Aortic Aneurysm: Evolving Controversies and Uncertainties.

Authors:  Davide Carino; Timur P Sarac; Bulat A Ziganshin; John A Elefteriades
Journal:  Int J Angiol       Date:  2018-05-29

5.  No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice.

Authors:  Romy Franken; Stijntje Hibender; Alexander W den Hartog; Teodora Radonic; Carlie J M de Vries; Aeilko H Zwinderman; Maarten Groenink; Barbara J M Mulder; Vivian de Waard
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

6.  Case report of a large cephalic vein aneurysm inducing heart failure in a renal transplant patient with radio-cephalic fistula for haemodialysis.

Authors:  Marco Panagrosso; Umberto Marcello Bracale; Luca Del Guercio; Alessia Viscardi; Antonio Peluso; Ettore Dinoto
Journal:  Int J Surg Case Rep       Date:  2020-08-27

7.  Abdominal aortic aneurysm repair in patient with a renal allograft: a case report.

Authors:  Hyung-Kee Kim; Jong-Pil Ryuk; Hyang Hee Choi; Sang-Hwy Kwon; Seung Huh
Journal:  J Korean Med Sci       Date:  2009-02-28       Impact factor: 2.153

8.  Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases.

Authors:  Shih-Hung Tsai; Po-Hsun Huang; Yu-Juei Hsu; Yi-Jen Peng; Chien-Hsing Lee; Jen-Chun Wang; Jaw-Wen Chen; Shing-Jong Lin
Journal:  Sci Rep       Date:  2016-07-01       Impact factor: 4.379

9.  Smooth muscle cell-specific Notch1 haploinsufficiency restricts the progression of abdominal aortic aneurysm by modulating CTGF expression.

Authors:  Jaspreet Sachdeva; Advitiya Mahajan; Jeeyun Cheng; Jeremy T Baeten; Brenda Lilly; Helena Kuivaniemi; Chetan P Hans
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.